Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Chemoradiotherapy × Clear all

NCT01118676 2026-04-14

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung

NCT04913311 2026-02-19

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06810609 2026-01-27

InDuRanS

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT07264647 2025-12-04

Neoadjuvant Chemo-immunotherapy for Stage III PD-L1 Positive Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT02788461 2025-09-18

PET-BOOST

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06998719 2025-05-31

ACCESS

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06908070 2025-04-03

CROWD

Phase 4 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT04866017 2024-10-31

A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer

Phase 3 Terminated

63 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT02805530 2023-05-06

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Phase NA Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms, Multiple Primary

NCT04958993 2022-02-25

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT01066234 2021-03-22

Adjuvant CCRT vs CT in Minimal N2 NSCLC

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT03598517 2020-08-25

High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

Phase NA Unknown

Carcinoma, Non-Small-Cell Lung

NCT03745222 2020-07-15

RATIONALE001

Phase 3 Terminated

1 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03672136 2018-09-14

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00431613 2015-05-29

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT02215356 2014-08-13

Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01494558 2011-12-19

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung

NCT00686322 2011-09-15

Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00490659 2007-06-25

Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung